pharmaphorum

AUGUST 23, 2021

The COVID-19 pandemic accelerated the development of mRNA-based vaccines, and its influence has now extended to DNA-based shots as well, with Zydus Cadila’s ZyCoV-D getting emergency use authorisation in India. Proponents of the approach claim that DNA vaccines may have advantages over other technologies like mRNA.

DNA 98

DNA Vaccination Vaccine Genetic Engineering 98

Roots Analysis

DECEMBER 12, 2021

DNA data storage involves encoding and decoding binary data to and from synthesized strands of DNA. DNA data storage is an innovative technology that works by encoding large digital data sequences of binary form (0s and 1s) into DNA sequences (Adenine (A), Guanine (G), Cytosine (C) and Thymine (T)). DNA Storage.

DNA 52

DNA Research Engineer Marketing 52

BioTech 365

DECEMBER 1, 2020

DNA sequencing Market – Growth, Trends, and Forecasts (2020 – 2024) DNA sequencing Market – Growth, Trends, and Forecasts (2020 – 2024) LONDON–(BUSINESS WIRE)–#DNASequencingMarket–The DNA sequencing market is poised to grow by USD 12.5

DNA 40

DNA Marketing 40

BioTech 365

DECEMBER 21, 2021

Global In Situ Hybridization Market Segment Forecasts 2021-2028: DNA Probes Segment Forecast to Maintain Dominance Due to Increasing DNA-based Studies – ResearchAndMarkets.com Global In Situ Hybridization Market Segment Forecasts 2021-2028: DNA Probes Segment Forecast to Maintain Dominance Due to Increasing … Continue reading →

DNA 40

DNA Marketing 40

STAT News

FEBRUARY 7, 2023

firm affiliated with Chinese sequencing giant BGI, on Tuesday announced plans to launch a new line of sequencers it says can decode DNA in larger amounts — and at lower costs — than any instrument on the market. times the max output of a line of new high-end sequencers that Illumina , the market leader, recently launched.

Genome 98

Genome Genomics DNA Marketing 98

Drug Discovery World

NOVEMBER 29, 2022

Using artificial intelligence, researchers at Chalmers University of Technology, Sweden have succeeded in designing synthetic DNA that controls the cells’ protein production. . First it was about being able to fully ‘read’ the DNA molecule’s instructions.

DNA 52

DNA Development Research Drugs 52

BioTech 365

SEPTEMBER 2, 2021

Global DNA Sequencing Research Report 2021: Focus on Research, Applied and Clinical Markets – ResearchAndMarkets.com Global DNA Sequencing Research Report 2021: Focus on Research, Applied and Clinical Markets – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Global DNA Sequencing: Research, Applied and Clinical Markets” (..)

DNA 40

DNA Research Marketing 40

BioTech 365

FEBRUARY 3, 2022

DNA Methyltransferase Inhibitor Drug Pipeline Market Research Report 2022 Featuring Rexahn Pharmaceuticals, SuperGen, & SignalRx Pharmaceuticals – ResearchAndMarkets.com DNA Methyltransferase Inhibitor Drug Pipeline Market Research Report 2022 Featuring Rexahn Pharmaceuticals, SuperGen, & SignalRx Pharmaceuticals – ResearchAndMarkets.com (..)

DNA 40

DNA Marketing Research Drugs 40

BioTech 365

JUNE 25, 2021

Africa DNA-RNA Sample Preparation Market Report 2021: Prospects, Trends Analysis, Market Size and Forecasts up to 2025 – ResearchAndMarkets.com Africa DNA-RNA Sample Preparation Market Report 2021: Prospects, Trends Analysis, Market Size and Forecasts up to 2025 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The … Continue (..)

RNA 40

RNA DNA Marketing 40

BioPharma Reporter

OCTOBER 5, 2023

Researchers from Chung-Ang University, Korea have developed a novel DNA biosensor which could result in early diagnosis of cervical cancer.

DNA 52

DNA Development Research Regulation 52

pharmaphorum

DECEMBER 3, 2020

Germany’s Merck KGaA has joined with UK-based Artios Pharma in a potential multi-billion dollar deal to investigate novel DNA damage response targets in cancer. The principle of DNA damage response is already being exploited by AstraZeneca and other companies with their poly (ADP-ribose) polymerase (PARP) inhibitor drugs.

DNA 72

DNA Genetics Research Sales 72

BioTech 365

JUNE 9, 2021

DNA Sequencing Products Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026 – ResearchAndMarkets.com DNA Sequencing Products Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “DNA Sequencing Products (..)

DNA 40

DNA Production Marketing 40

BioTech 365

DECEMBER 9, 2020

Global DNA Forensic Solution Market Research 2020-2024 | COVID-19 Industry Impact Analysis | Technavio Global DNA Forensic Solution Market Research 2020-2024 | COVID-19 Industry Impact Analysis | Technavio LONDON–(BUSINESS WIRE)–#Technavio–The DNA forensic solution market is expected to grow by USD … Continue (..)

DNA 52

DNA Marketing Research 52

BioPharma Reporter

SEPTEMBER 8, 2022

A collaboration between Touchlight and Lonza expands the Swiss CDMOâs end-to-end offering for mRNA manufacturing with an additional, differentiated source of DNA raw material, the UK biotechâs doggybone DNA (dbDNA).

DNA 52

DNA Manufacturing Regulation Marketing 52

BioTech 365

JUNE 15, 2021

Viral Vectors and Plasmid DNA Manufacturing Market Size, Share & Trends Analysis Report 2021 – 2028 – ResearchAndMarkets.com Viral Vectors and Plasmid DNA Manufacturing Market Size, Share & Trends Analysis Report 2021 – 2028 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Viral Vectors … (..)

DNA 40

DNA Manufacturing Marketing 40

BioTech 365

OCTOBER 7, 2021

Global DNA & RNA Banking Services (Storage Service, Quality Control Service) Market Trends, Analysis & Forecasts Report 2021-2028 – ResearchAndMarkets.com Global DNA & RNA Banking Services (Storage Service, Quality Control Service) Market Trends, Analysis & Forecasts Report 2021-2028 – ResearchAndMarkets.com … (..)

RNA 40

RNA DNA Marketing 40

pharmaphorum

JANUARY 6, 2021

Pharma companies are always talking about moving ‘beyond the pill’, and Pfizer’s new brand identity embodies that – it’s decades old pill-like logo has been replaced with a DNA double helix that it says reflects its commitment to breakthrough science. Encoded within a successful emblem is a company’s DNA – its history, its future.

DNA 113

DNA Branding Vaccination Vaccine 113

BioPharma Reporter

FEBRUARY 3, 2022

Polyplus, a provider of transfection reagents, has acquired e-Zyvec, a France-based provider of DNA design and production services for tailor-made DNA vectors to expand expertise in plasmid DNA vector engineering.

DNA 52

DNA Reagent Engineer Production 52

BioTech 365

MAY 11, 2021

Million Worldwide Recombinant DNA Technology Industry to 2027 – Impact of COVID-19 on the Market – ResearchAndMarkets.com $609.8

Recombinant DNA Technology 40

Recombinant DNA Technology DNA Marketing 40

BioTech 365

JANUARY 13, 2021

Applied DNA Announces Closing of $15 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules Applied DNA Announces Closing of $15 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules STONY BROOK, N.Y.–(BUSINESS NASDAQ: APDN) … Continue reading →

DNA 52

DNA Marketing 52

BioTech 365

JANUARY 13, 2022

The Global Viral Vectors and Plasmid DNA Global Market will Grow to USD 1.34 billion by 2026, at a CAGR of 20% – ResearchAndMarkets.com The Global Viral Vectors and Plasmid DNA Global Market will Grow to USD 1.34 billion by … Continue reading →

DNA 40

DNA Marketing 40

BioTech 365

JUNE 27, 2021

Eurofins to Acquire DNA Diagnostics Center to Grow Genetic Testing Capabilities and Significantly Expand Further Into the Consumer Testing Market Eurofins to Acquire DNA Diagnostics Center to Grow Genetic Testing Capabilities and Significantly Expand Further Into the Consumer Testing Market … Continue reading →

DNA 52

DNA Genetics Marketing 52

pharmaphorum

JULY 2, 2021

Zydus Cadila has filed for emergency use approval (EUA) in India of its plasmid DNA-based vaccine for COVID-19, which if given a green light could become the first shot of its type to be cleared for widespread use in humans. . The post Zydus Cadila nears world-first human plasmid DNA vaccine approval appeared first on.

DNA 83

DNA Vaccination Vaccine Clinical Trials 83

Outsourcing Pharma

MAY 25, 2023

A company developing small molecule therapeutics targeting DNA Damage Response (DDR) in order to treat patients with a broad range of cancers has its first assay development customer.

DNA 52

DNA Clinical Trials Clinical Trials Development 52

BioTech 365

SEPTEMBER 20, 2021

Global Gene Expression Market Size, Share & Trends Analysis 2021-2028 by Product (DNA Chip/Microarray, Kits & Reagents), Technique (Promoter Analysis, RNA Exp.) – ResearchAndMarkets.com Global Gene Expression Market Size, Share & Trends Analysis 2021-2028 by Product (DNA Chip/Microarray, Kits & … Continue reading → (..)

Gene Expression 40

Gene Expression Reagent DNA RNA 40

BioTech 365

OCTOBER 6, 2021

Global DNA Damage Response Targeting Therapeutics Markets, 2021-2030 by Target Disease Indication, Therapeutic Area, Target Molecule, Type of Molecule, Route of Administration – ResearchAndMarkets.com Global DNA Damage Response Targeting Therapeutics Markets, 2021-2030 by Target Disease Indication, Therapeutic Area, Target Molecule, … Continue (..)

DNA 40

DNA Marketing 40

BioTech 365

SEPTEMBER 21, 2020

DUBLIN–(BUSINESS WIRE)–The “DNA Sequencing – Technologies, Markets & Companies” report from Jain PharmaBiotech has been added to ResearchAndMarkets.com’s offering. This report briefly reviews basics of human genome variations, development of sequencing technologies, and their applications.

DNA 40

DNA Marketing Genome Genomics 40

BioTech 365

OCTOBER 28, 2020

DUBLIN–(BUSINESS WIRE)–The “Viral Vector and Plasmid DNA Manufacturing Market – Growth, Trends, and Forecasts (2020 – 2025)” report has been added to ResearchAndMarkets.com’s offering.

DNA 40

DNA Manufacturing Gene Therapy Marketing 40

BioTech 365

JANUARY 17, 2022

Targeted Immunotherapy in Oncology Market Research Report 2021: Development of New Targeted Immunotherapies, Particularly Those that Deliver Therapeutic DNA and Proteins – ResearchAndMarkets.com Targeted Immunotherapy in Oncology Market Research Report 2021: Development of New Targeted Immunotherapies, Particularly Those that Deliver … (..)

DNA 40

DNA Protein Marketing Development 40

pharmaphorum

APRIL 13, 2022

Slick productions to maximise digital opportunities and algorithm-powered insights play a strong role in linking industry campaigns to the healthcare coal face but deeper connections can be mined by making coaching part of an organisation’s DNA. Coaching has to be part of the DNA,” he adds. “It A critical mind-shift is needed.

DNA 88

DNA Sales Development Production 88

BioTech 365

FEBRUARY 12, 2021

United States Travel Vaccines Market Research Report 2021: Focus on Attenuated Vaccines, Conjugate Vaccines, DNA Vaccines, Inactive Vaccines, and Recombinant Vector Vaccines – ResearchAndMarkets.com United States Travel Vaccines Market Research Report 2021: Focus on Attenuated Vaccines, Conjugate Vaccines, DNA Vaccines, … Continue reading (..)

DNA 40

DNA Vaccination Vaccine Marketing 40

BioTech 365

AUGUST 17, 2020

4basebio AG / Key word(s): Strategic Company Decision 4basebio AG announces process for spin-off and separate stock market listing for its DNA business 17-Aug-2020 / 11:32 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation … Continue reading →

DNA 40

DNA Marketing Regulation 40

BioTech 365

AUGUST 14, 2020

DUBLIN–(BUSINESS WIRE)–The “Global Viral Vectors & Plasmid DNA Market 2020-2030: COVID-19 Implications and Growth” report has been added to ResearchAndMarkets.com’s offering. The global viral vectors & plasmid DNA market is expected to grow from $0.46

DNA 40

DNA Marketing 40

Pharmaceutical Technology

APRIL 3, 2023

The deal will see Polyplus join the German life science group’s portfolio allowing the latter to leverage expertise in transfection reagents and plasmid DNA for gene therapy. to complete an in-house plasmid DNA facility in Marburg, Germany. “In In February 2023, the mRNA specialist BioNTech invested $43.8m

Gene Therapy 246

Gene Therapy Gene DNA Reagent 246

pharmaphorum

AUGUST 10, 2021

Europe market has proved so hostile to gene therapies when it comes to pricing and reimbursement for gene therapies that bluebird bio has decided to quit the market altogether, according to Andrew Obenshain, president of its severe genetic diseases unit. market and will wind down in Europe. market and will wind down in Europe.

Gene Therapy 135

Gene Therapy Gene Marketing Genetic Disease 135

BioPharma Reporter

JULY 6, 2022

Touchlight has agreed to a non-exclusive patent license for Pfizer to utilize its enzymatic doggybone DNA (dbDNA).

DNA 52

DNA Licensing Licensing Production 52

Drug Discovery World

AUGUST 14, 2023

While CGT is still an emerging market, its growth has accelerated over the last five years, resulting in a wave of products approved by the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Driven by the rapid pace of innovation, the market for CGTs is expected to grow from $4.4 billion in 2020 to $15.5

Gene Therapy 52

Gene Therapy Marketing Gene DNA 52